Speaker Profile

M.D., Director at BioRepository & Precision Pathology Center, Duke University
Biography

As Director of the CAP-accredited BRPC, Dr. McCall serves as principal investigator for Duke’s institutional research biobanking protocol which has gathered the informed consent of over 5,000 patient-participants so far. She co-leads the Precision Cancer Medicine Initiative at Duke which includes maximizing access to anatomic and genomic pathology data for research and facilitating Duke’s participation in the American Association of Cancer Research’s ‘GENIE’ data-sharing project. Dr. McCall is a member of the International Society of Biological and Environmental Repositories (ISBER) Standards Committee and is currently serving as the Vice-chair of the Biorepository Accreditation Program Committee of the College of American Pathologists (CAP). She is an Associate Professor of Pathology at Duke University who is also board-certified in Clinical Informatics. She is a GI Pathologist with a focus on esophageal cancer who has served on many translational science investigations including The Cancer Genome Atlas (TCGA) GI projects.

Session Abstract – PMWC 2019 Silicon Valley

Session Synopsis: Biobanking is crucial to biomedicine. Biobanks are changing the face of medical research by making available a wealth of material needed for broad research, to investigate cancerous tissues, allow access to healthy controls, and more. This session features leaders from across several organizations – Astra Zeneca, Duke, Maccabi Research Institute, and Quintiles – discussing the importance, as well as the challenges of biobanking for personalized medicine, touching on various population-based applications, data access policy, and other aspects of building and maintaining a biobank.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

You have Successfully Subscribed!